Global Cholera Vaccines Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Market Overview
The global Cholera Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cholera Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cholera Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cholera Vaccines market has been segmented into:
Dukoral
Shanchol
Vaxchora
Others
By Application, Cholera Vaccines has been segmented into:
Oral
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cholera Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Cholera Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cholera Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Cholera Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cholera Vaccines Market Share Analysis
Cholera Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cholera Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cholera Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Cholera Vaccines are:
Shantha Biotechnics Private Limited
Emergent BioSolutions, Inc.
Merck and Co., Inc.
PaxVax, Inc.
Pfizer, Inc.
Valneva SE
Takeda Pharmaceutical Co., Ltd.
Astellas Pharma, Inc.
GlaxoSmithKline plc (GSK)
Mitsubishi Tanabe Pharma Corporation
Table of Contents
1 Cholera Vaccines Market Overview
1.1 Product Overview and Scope of Cholera Vaccines
1.2 Classification of Cholera Vaccines by Type
1.2.1 Global Cholera Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cholera Vaccines Revenue Market Share by Type in 2019
1.2.3 Dukoral
1.2.4 Shanchol
1.2.5 Vaxchora
1.2.6 Others
1.3 Global Cholera Vaccines Market by Application
1.3.1 Overview: Global Cholera Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oral
1.3.3 Others
1.4 Global Cholera Vaccines Market by Regions
1.4.1 Global Cholera Vaccines Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cholera Vaccines (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cholera Vaccines Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cholera Vaccines Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cholera Vaccines Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cholera Vaccines Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cholera Vaccines Status and Prospect (2015-2025)
2 Company Profiles
2.1 Shantha Biotechnics Private Limited
2.1.1 Shantha Biotechnics Private Limited Details
2.1.2 Shantha Biotechnics Private Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Shantha Biotechnics Private Limited SWOT Analysis
2.1.4 Shantha Biotechnics Private Limited Product and Services
2.1.5 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.2 Emergent BioSolutions, Inc.
2.2.1 Emergent BioSolutions, Inc. Details
2.2.2 Emergent BioSolutions, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Emergent BioSolutions, Inc. SWOT Analysis
2.2.4 Emergent BioSolutions, Inc. Product and Services
2.2.5 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck and Co., Inc.
2.3.1 Merck and Co., Inc. Details
2.3.2 Merck and Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck and Co., Inc. SWOT Analysis
2.3.4 Merck and Co., Inc. Product and Services
2.3.5 Merck and Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.4 PaxVax, Inc.
2.4.1 PaxVax, Inc. Details
2.4.2 PaxVax, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 PaxVax, Inc. SWOT Analysis
2.4.4 PaxVax, Inc. Product and Services
2.4.5 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer, Inc.
2.5.1 Pfizer, Inc. Details
2.5.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer, Inc. SWOT Analysis
2.5.4 Pfizer, Inc. Product and Services
2.5.5 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.6 Valneva SE
2.6.1 Valneva SE Details
2.6.2 Valneva SE Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Valneva SE SWOT Analysis
2.6.4 Valneva SE Product and Services
2.6.5 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda Pharmaceutical Co., Ltd.
2.7.1 Takeda Pharmaceutical Co., Ltd. Details
2.7.2 Takeda Pharmaceutical Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda Pharmaceutical Co., Ltd. SWOT Analysis
2.7.4 Takeda Pharmaceutical Co., Ltd. Product and Services
2.7.5 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.8 Astellas Pharma, Inc.
2.8.1 Astellas Pharma, Inc. Details
2.8.2 Astellas Pharma, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Astellas Pharma, Inc. SWOT Analysis
2.8.4 Astellas Pharma, Inc. Product and Services
2.8.5 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.9 GlaxoSmithKline plc (GSK)
2.9.1 GlaxoSmithKline plc (GSK) Details
2.9.2 GlaxoSmithKline plc (GSK) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GlaxoSmithKline plc (GSK) SWOT Analysis
2.9.4 GlaxoSmithKline plc (GSK) Product and Services
2.9.5 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mitsubishi Tanabe Pharma Corporation
2.10.1 Mitsubishi Tanabe Pharma Corporation Details
2.10.2 Mitsubishi Tanabe Pharma Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mitsubishi Tanabe Pharma Corporation SWOT Analysis
2.10.4 Mitsubishi Tanabe Pharma Corporation Product and Services
2.10.5 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cholera Vaccines Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cholera Vaccines Players Market Share
3.2.2 Top 10 Cholera Vaccines Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cholera Vaccines Revenue and Market Share by Regions
4.2 North America Cholera Vaccines Revenue and Growth Rate (2015-2020)
4.3 Europe Cholera Vaccines Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cholera Vaccines Revenue and Growth Rate (2015-2020)
4.5 South America Cholera Vaccines Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cholera Vaccines Revenue and Growth Rate (2015-2020)
5 North America Cholera Vaccines Revenue by Countries
5.1 North America Cholera Vaccines Revenue by Countries (2015-2020)
5.2 USA Cholera Vaccines Revenue and Growth Rate (2015-2020)
5.3 Canada Cholera Vaccines Revenue and Growth Rate (2015-2020)
5.4 Mexico Cholera Vaccines Revenue and Growth Rate (2015-2020)
6 Europe Cholera Vaccines Revenue by Countries
6.1 Europe Cholera Vaccines Revenue by Countries (2015-2020)
6.2 Germany Cholera Vaccines Revenue and Growth Rate (2015-2020)
6.3 UK Cholera Vaccines Revenue and Growth Rate (2015-2020)
6.4 France Cholera Vaccines Revenue and Growth Rate (2015-2020)
6.5 Russia Cholera Vaccines Revenue and Growth Rate (2015-2020)
6.6 Italy Cholera Vaccines Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cholera Vaccines Revenue by Countries
7.1 Asia-Pacific Cholera Vaccines Revenue by Countries (2015-2020)
7.2 China Cholera Vaccines Revenue and Growth Rate (2015-2020)
7.3 Japan Cholera Vaccines Revenue and Growth Rate (2015-2020)
7.4 Korea Cholera Vaccines Revenue and Growth Rate (2015-2020)
7.5 India Cholera Vaccines Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cholera Vaccines Revenue and Growth Rate (2015-2020)
8 South America Cholera Vaccines Revenue by Countries
8.1 South America Cholera Vaccines Revenue by Countries (2015-2020)
8.2 Brazil Cholera Vaccines Revenue and Growth Rate (2015-2020)
8.3 Argentina Cholera Vaccines Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cholera Vaccines by Countries
9.1 Middle East & Africa Cholera Vaccines Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cholera Vaccines Revenue and Growth Rate (2015-2020)
9.3 UAE Cholera Vaccines Revenue and Growth Rate (2015-2020)
9.4 Egypt Cholera Vaccines Revenue and Growth Rate (2015-2020)
9.5 South Africa Cholera Vaccines Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cholera Vaccines Revenue and Market Share by Type (2015-2020)
10.2 Global Cholera Vaccines Market Forecast by Type (2019-2024)
10.3 Dukoral Revenue Growth Rate (2015-2025)
10.4 Shanchol Revenue Growth Rate (2015-2025)
10.5 Vaxchora Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Cholera Vaccines Market Segment by Application
11.1 Global Cholera Vaccines Revenue Market Share by Application (2015-2020)
11.2 Cholera Vaccines Market Forecast by Application (2019-2024)
11.3 Oral Revenue Growth (2015-2020)
11.4 Others Revenue Growth (2015-2020)
12 Global Cholera Vaccines Market Size Forecast (2021-2025)
12.1 Global Cholera Vaccines Market Size Forecast (2021-2025)
12.2 Global Cholera Vaccines Market Forecast by Regions (2021-2025)
12.3 North America Cholera Vaccines Revenue Market Forecast (2021-2025)
12.4 Europe Cholera Vaccines Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cholera Vaccines Revenue Market Forecast (2021-2025)
12.6 South America Cholera Vaccines Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cholera Vaccines Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Cholera Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cholera Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cholera Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cholera Vaccines Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Shantha Biotechnics Private Limited Corporate Information, Location and Competitors
Table 6. Shantha Biotechnics Private Limited Cholera Vaccines Major Business
Table 7. Shantha Biotechnics Private Limited Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 8. Shantha Biotechnics Private Limited SWOT Analysis
Table 9. Shantha Biotechnics Private Limited Cholera Vaccines Product and Solutions
Table 10. Shantha Biotechnics Private Limited Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Emergent BioSolutions, Inc. Corporate Information, Location and Competitors
Table 12. Emergent BioSolutions, Inc. Cholera Vaccines Major Business
Table 13. Emergent BioSolutions, Inc. Cholera Vaccines Total Revenue (USD Million) (2018-2019)
Table 14. Emergent BioSolutions, Inc. SWOT Analysis
Table 15. Emergent BioSolutions, Inc. Cholera Vaccines Product and Solutions
Table 16. Emergent BioSolutions, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck and Co., Inc. Corporate Information, Location and Competitors
Table 18. Merck and Co., Inc. Cholera Vaccines Major Business
Table 19. Merck and Co., Inc. Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 20. Merck and Co., Inc. SWOT Analysis
Table 21. Merck and Co., Inc. Cholera Vaccines Product and Solutions
Table 22. Merck and Co., Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. PaxVax, Inc. Corporate Information, Location and Competitors
Table 24. PaxVax, Inc. Cholera Vaccines Major Business
Table 25. PaxVax, Inc. Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 26. PaxVax, Inc. SWOT Analysis
Table 27. PaxVax, Inc. Cholera Vaccines Product and Solutions
Table 28. PaxVax, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer, Inc. Corporate Information, Location and Competitors
Table 30. Pfizer, Inc. Cholera Vaccines Major Business
Table 31. Pfizer, Inc. Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer, Inc. SWOT Analysis
Table 33. Pfizer, Inc. Cholera Vaccines Product and Solutions
Table 34. Pfizer, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Valneva SE Corporate Information, Location and Competitors
Table 36. Valneva SE Cholera Vaccines Major Business
Table 37. Valneva SE Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 38. Valneva SE SWOT Analysis
Table 39. Valneva SE Cholera Vaccines Product and Solutions
Table 40. Valneva SE Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Takeda Pharmaceutical Co., Ltd. Corporate Information, Location and Competitors
Table 42. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Major Business
Table 43. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 44. Takeda Pharmaceutical Co., Ltd. SWOT Analysis
Table 45. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Product and Solutions
Table 46. Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Astellas Pharma, Inc. Corporate Information, Location and Competitors
Table 48. Astellas Pharma, Inc. Cholera Vaccines Major Business
Table 49. Astellas Pharma, Inc. Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 50. Astellas Pharma, Inc. SWOT Analysis
Table 51. Astellas Pharma, Inc. Cholera Vaccines Product and Solutions
Table 52. Astellas Pharma, Inc. Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GlaxoSmithKline plc (GSK) Corporate Information, Location and Competitors
Table 54. GlaxoSmithKline plc (GSK) Cholera Vaccines Major Business
Table 55. GlaxoSmithKline plc (GSK) Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 56. GlaxoSmithKline plc (GSK) SWOT Analysis
Table 57. GlaxoSmithKline plc (GSK) Cholera Vaccines Product and Solutions
Table 58. GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Mitsubishi Tanabe Pharma Corporation Corporate Information, Location and Competitors
Table 60. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Major Business
Table 61. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Total Revenue (USD Million) (2017-2018)
Table 62. Mitsubishi Tanabe Pharma Corporation SWOT Analysis
Table 63. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Product and Solutions
Table 64. Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Cholera Vaccines Revenue (Million USD) by Players (2015-2020)
Table 66. Global Cholera Vaccines Revenue Share by Players (2015-2020)
Table 67. Global Cholera Vaccines Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Cholera Vaccines Revenue Market Share by Regions (2015-2020)
Table 69. North America Cholera Vaccines Revenue by Countries (2015-2020)
Table 70. North America Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Table 71. Europe Cholera Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Cholera Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Cholera Vaccines Revenue by Countries (2015-2020)
Table 74. South America Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Cholera Vaccines Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Table 77. Global Cholera Vaccines Revenue (Million USD) by Type (2015-2020)
Table 78. Global Cholera Vaccines Revenue Share by Type (2015-2020)
Table 79. Global Cholera Vaccines Revenue Forecast by Type (2021-2025)
Table 80. Global Cholera Vaccines Revenue by Application (2015-2020)
Table 81. Global Cholera Vaccines Revenue Share by Application (2015-2020)
Table 82. Global Cholera Vaccines Revenue Forecast by Application (2021-2025)
Table 83. Global Cholera Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cholera Vaccines Picture
Figure 2. Global Cholera Vaccines Revenue Market Share by Type in 2019
Figure 3. Dukoral Picture
Figure 4. Shanchol Picture
Figure 5. Vaxchora Picture
Figure 6. Others Picture
Figure 7. Cholera Vaccines Revenue Market Share by Application in 2019
Figure 8. Oral Picture
Figure 9. Others Picture
Figure 10. Global Cholera Vaccines Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Cholera Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Cholera Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Cholera Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Cholera Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Cholera Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cholera Vaccines Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Cholera Vaccines Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Cholera Vaccines Revenue Market Share in 2019
Figure 19. Global Top 10 Players Cholera Vaccines Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Cholera Vaccines Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Cholera Vaccines Revenue Market Share by Regions (2015-2020)
Figure 23. Global Cholera Vaccines Revenue Market Share by Regions in 2018
Figure 24. North America Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 25. Europe Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 27. South America Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 29. North America Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Figure 30. North America Cholera Vaccines Revenue Market Share by Countries in 2019
Figure 31. USA Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 32. Canada Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 34. Europe Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Cholera Vaccines Revenue Market Share by Countries in 2019
Figure 36. Germany Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 37. UK Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 38. France Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 39. Russia Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 40. Italy Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Cholera Vaccines Revenue Market Share by Countries in 2019
Figure 43. China Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 44. Japan Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 45. Korea Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 46. India Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 48. South America Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Figure 49. South America Cholera Vaccines Revenue Market Share by Countries in 2019
Figure 50. Brazil Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Cholera Vaccines Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Cholera Vaccines Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 55. UAE Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Cholera Vaccines Revenue and Growth Rate (2015-2020)
Figure 58. Global Cholera Vaccines Revenue Share by Type (2015-2020)
Figure 59. Global Cholera Vaccines Revenue Share by Type in 2019
Figure 60. Global Cholera Vaccines Market Share Forecast by Type (2021-2025)
Figure 61. Global Dukoral Revenue Growth Rate (2015-2020)
Figure 62. Global Shanchol Revenue Growth Rate (2015-2020)
Figure 63. Global Vaxchora Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global Cholera Vaccines Revenue Share by Application (2015-2020)
Figure 66. Global Cholera Vaccines Revenue Share by Application in 2019
Figure 67. Global Cholera Vaccines Market Share Forecast by Application (2021-2025)
Figure 68. Global Oral Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Cholera Vaccines Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Cholera Vaccines Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Cholera Vaccines Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Cholera Vaccines Revenue Market Forecast (2021-2025)
Figure 74. Europe Cholera Vaccines Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Cholera Vaccines Revenue Market Forecast (2021-2025)
Figure 76. South America Cholera Vaccines Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Cholera Vaccines Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Shantha Biotechnics Private Limited
Emergent BioSolutions, Inc.
Merck and Co., Inc.
PaxVax, Inc.
Pfizer, Inc.
Valneva SE
Takeda Pharmaceutical Co., Ltd.
Astellas Pharma, Inc.
GlaxoSmithKline plc (GSK)
Mitsubishi Tanabe Pharma Corporation
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets